MENU
ADCT
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
ADC Therapeutics SA (ADCT) Earnings Date & Reports
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more
A.I. Advisor
published Earnings
ADCT is expected to report earnings to rise 62.85% to -21 cents per share on August 11
Q2'26
Est.
$-0.21
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.20
Q3'25
Beat
by $0.17
Q2'25
Beat
by $0.14
The last earnings report on May 04 showed earnings per share of -12 cents, beating the estimate of -20 cents. With 1.73M shares outstanding, the current market capitalization sits at 138.64M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com